| Drug delivery applications for superporous hydrogels DJ Mastropietro, H Omidian, K Park Expert opinion on drug delivery 9 (1), 71-89, 2012 | 96 | 2012 |
| Rheology in pharmaceutical formulations-a perspective DJ Mastropietro, R Nimroozi, H Omidian J. Dev. Drugs 2 (2), 1-6, 2013 | 79 | 2013 |
| Current approaches in tamper-resistant and abuse-deterrent formulations DJ Mastropietro, H Omidian Drug development and industrial pharmacy 39 (5), 611-624, 2013 | 65 | 2013 |
| Abuse-deterrent formulations: part 2: commercial products and proprietary technologies DJ Mastropietro, H Omidian Expert opinion on pharmacotherapy 16 (3), 305-323, 2015 | 50 | 2015 |
| Polymers in oral drug delivery DJ Mastropietro, K Park, H Omidian Elsevier, 2017 | 36 | 2017 |
| Abuse-deterrent formulations: part 1–development of a formulation-based classification system DJ Mastropietro, H Omidian Expert opinion on drug metabolism & toxicology 11 (2), 193-204, 2015 | 35 | 2015 |
| Crush resistance and insufflation potential of poly (ethylene oxide)-based abuse deterrent formulations S Muppalaneni, DJ Mastropietro, H Omidian Expert Opinion on Drug Delivery 13 (10), 1375-1382, 2016 | 16 | 2016 |
| Prevalence and trends of cellulosics in pharmaceutical dosage forms DJ Mastropietro, H Omidian Drug Development and Industrial Pharmacy 39 (2), 382-392, 2013 | 14 | 2013 |
| Determining abuse deterrence performance of poly (ethylene oxide) using a factorial design Y Joshi, S Muppalaneni, A Omidian, DJ Mastropietro, H Omidian Advanced Pharmaceutical Bulletin 8 (3), 495, 2018 | 11 | 2018 |
| Deterred drug abuse using superabsorbent polymers DJ Mastropietro, S Muppalaneni, H Omidian Expert opinion on drug delivery 13 (11), 1523-1531, 2016 | 11 | 2016 |
| Swelling, strength, and biocompatibility of acrylate-based superporous hydrogel hybrids H Omidian, D Mastropietro, U Kandalam Journal of bioactive and compatible polymers 29 (1), 66-80, 2014 | 10 | 2014 |
| Surface cross-linked SAPs with improved swollen gel strength using diol compounds S Mojarad-Jabali, K Kabiri, Z Karami, DJ Mastropietro, H Omidian Journal of Macromolecular Science, Part A 57 (1), 62-71, 2020 | 9 | 2020 |
| Mucoadhesive drug delivery systems S Muppalaneni, D Mastropietro, H Omidian Engineering Polymer Systems for Improved Drug Delivery, 319-342, 2013 | 7 | 2013 |
| Reported methods of abuse for common prescription analgesic opioids A Omidian, DJ Mastropietro, H Omidian J Dev Drugs 3 (02), 1-3, 2013 | 7 | 2013 |
| Commercial abuse-deterrent dosage forms: clinical status DJ Mastropietro, H Omidian J Develop Drugs 2 (103), 1-6, 2013 | 7 | 2013 |
| Routes of opioid abuse and its novel deterrent formulations A Omidian, DJ Mastropietro, H Omidian Journal of Developing Drugs 4 (5), 1, 2015 | 6 | 2015 |
| Drug tampering and abuse deterrence DJ Mastropietro, H Omidian Journal of developing drugs 3 (1), 1-4, 2014 | 6 | 2014 |
| Shear-thinning rheology of the abuse-deterrent dosage form extracts D Mastropietro, S Muppalaneni, A Kariman, H Omidian J Develop Drugs 2 (3), 1-3, 2013 | 6 | 2013 |
| Deterring abuse of pharmaceutical products and alcohol H Omidian, DJ Mastropietro, S Muppalaneni US Patent App. 14/917,368, 2016 | 5 | 2016 |
| A new approach to determining the performance of superdisintegrants Y Joshi, D Mastropietro, S Muppalaneni, H Omidian Journal of Bioactive and Compatible Polymers 30 (1), 3-16, 2015 | 5 | 2015 |
Hossein OmidianProfessor of Pharmaceutical Sciencesnova.edu üzerinde doğrulanmış e-posta adresine sahip
